Showing results (71-80 of 224) with videos related to
Sort By:
Pageof 23
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 6, 2021
Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experienceLogan Moore, Trace Bartels, Daniel O Persky, et al.International Journal of Nursing Studies|December 8, 2009
The evolving professional nursing self-image of students in baccalaureate programs: a cross-sectional surveyKoen Milisen, Tinne De Busser, Annelore Kayaert, et al.International Journal of Clinical Pharmacy|August 5, 2019
Physicians' perceptions, expectations, and experiences of clinical pharmacists in Jordan-2017Linda Tahaineh, Mayyada Wazaify, Fedda Alomoush, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Detectability and appraisal thresholds of split pulse signals for the MemoPatch™ device, an electronic skin patch intended to deliver tactile medication reminder signals (study TS-104)Ivo Abraham, Wim De Geest, Jan De Geest, et al.Expert Review of Pharmacoeconomics & Outcomes Research|June 7, 2024
Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curvesMavis Obeng-Kusi, Jennifer R Martin, Denise Roe, et al.Clinical Lymphoma, Myeloma & Leukemia|July 18, 2021
Comparative Efficacy of First-Line Treatments of Chronic Lymphocytic Leukemia: Network Meta-Analyses of Survival CurvesNeda Alrawashdh, Daniel O Persky, Ali McBride, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 10, 2022
Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic LeukemiaNeda Alrawashdh, Ali McBride, Brian Erstad, et al.Critical Care Medicine|July 24, 2020
Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer PerspectiveMok Oh, Asad E Patanwala, Nimer Alkhatib, et al.Medical Devices (Auckland, N.Z.)|February 25, 2015
Detectability and acceptability of continuous pulse signals for the MemoPatch(®) device, an electronic skin patch intended to deliver tactile medication reminder signalsIvo Abraham, Jan De Geest, Wim De Geest, et al.Current Medical Research and Opinion|September 6, 2007
Patient and caregiver outcomes after 6 +/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT studyTony Mets, Maurits Vandewoude, Jean Jacquy, et al.Pageof 23